Integrated Analysis of Gut Microbiota and Fecal Metabolites in Chinese Patients With Rheumatoid Arthritis: Associations With Disease Activity

Jing Liang Xiang-Yu Wei Chen Shang Si-Qi Shao Wen-Ting Hao Yi-Le Ren

Oct 2026 · International Journal of Rheumatic Diseases · Vol 29 · 0 citations · 30 references

Medicine

TL;DR

This study aimed to delineate fecal microbiome and metabolomic signatures in RA and identify biomarkers associated with disease activity and identify biomarkers associated with disease activity.

Abstract

Rheumatoid arthritis (RA) is a chronic autoimmune disease with intestinal dysbiosis implicated through the gut–joint axis. This study aimed to delineate fecal microbiome and metabolomic signatures in RA and identify biomarkers associated with disease activity.

DOI PubMed Semantic Scholar

View source

Similar papers

Oct 2026

Distinct Gut Microbiota Signatures are Associated With Progression of Atherosclerosis in Patients With Psoriasis: Results From the EDSAP Study.

Psoriasis patients have an increased risk of accelerated atherosclerosis. Our findings suggest that there are distinctive gut microbiota signatures in psoriasis patients that associate to atherosclerosis progression.

Carlota Abbad-Jaime de Aragón, E. Berná-Rico, F. Neria et al. · British Journal of Dermatolo... · 0 citations

Review Open access Oct 2026

Microbiome‐Immune Crosstalk in Inflammatory Skin Diseases: Mechanisms and Therapeutic Potential of Probiotics

The gut–skin axis links intestinal microbial activity with inflammatory skin disease, yet findings across atopic dermatitis, acne vulgaris, and psoriasis remain inconsistent. This review examines how disease biology and host context shape microbiome‐related effects and responses to probiotics.

Pranvi Sharma, Tanaka Nhokwara, Jaswinder Singh et al. · Immunity, Inflammation and D... · 0 citations

Open access Oct 2026

Impact of YAQ001 on the Gut Microbiome, Permeability and Markers of Systemic Inflammation in Patients With Cirrhosis

YAQ001 is a novel, non‐absorbable, gut‐restricted, multiporous, carbon bead adsorbent. Pre‐clinical studies and a clinical trial suggested its therapeutic potential and safety in patients with cirrhosis. This substudy aimed to explore the effects of YAQ001 on the gut microbiome and their exploratory association with bi...

Jin-Xia Liu, F. Garcia-Guevara, J. Macnaughtan et al. · Liver international (Print) · 0 citations

Review Open access Oct 2026

Tripartite Interplay of Epithelial, Immune, and Microbiota Dysregulation in Crohn's Disease: Mechanisms and Translational Strategies

Cumulative evidence supports the role of the intestinal epithelial barrier, immune system and gut microbiota in the progression of Crohn's disease.

Qing-Qin Lai, Qing-Yun Zhang, Wei-Peng Yang et al. · Immunity, Inflammation and D... · 0 citations

Open access Sep 2026

The effect of a tailored dietary intervention on serum biomarkers and faecal microbiome composition in people with HIV at risk of cardiovascular disease

People with HIV (PWH) are at higher risk of cardiovascular disease (CVD) despite spontaneous or antiretroviral therapy‐induced long‐lasting suppressed viremia. Traditional and HIV‐specific factors have been identified, but CVD incidence and mortality remain high. A microbiome is a community of germs living close to the...

F. Ranzani, C. Montrucchio, I. Ferrocino et al. · HIV Medicine · 0 citations

Editorial Open access Oct 2026

Editorial for Special Issue “Dietary and Animal Gut Microbiota”

The gut microbiota has long been recognized as a critical "hidden organ" that interacts dynamically with host animals, playing irreplaceable roles in regulating nutrient metabolism, shaping immune function, and maintaining systemic health [...].

Y. Pi · Microorganisms · 0 citations